The ability of thiram to inhibit eukaryotic topoisomerase II and to damage DNA.
Rahden-Staroń
I
I
Department of Biochemistry, Institute of Biopharmacy, Medical School, Warsaw, Poland.
Czeczot
H
H
Kowalska-Loth
B
B
D000818:Animals; D004249:DNA Damage; D004264:DNA Topoisomerases, Type I / Q000187:drug effects; D043382:DNA-Formamidopyrimidine Glycosylase; D009153:Mutagens / Q000633:toxicity*; D009699:N-Glycosyl Hydrolases / Q000235:genetics / Q000378:metabolism; D013893:Thiram / Q000633:toxicity*; D059005:Topoisomerase II Inhibitors
D009153:Mutagens; D059005:Topoisomerase II Inhibitors; D013893:Thiram; D009699:N-Glycosyl Hydrolases; D043382:DNA-Formamidopyrimidine Glycosylase; D004264:DNA Topoisomerases, Type I